Capgemini Shares Drop 2.5% and Threaten Support at €87.82

The Stock Approaches Its €87.82 Support Under Selling Pressure

Capgemini falls 2.76% to €88.04 during the session, positioning the stock among the steepest declines of the CAC 40, just behind Kering. The decline brings the price to the brink of its support at €87.82, previously identified as a defense zone following the drop on June 18, which had taken the stock to its lowest since the health crisis. The stock has lost 13.64% over the month and nearly 40% over the year, a heavy dynamic that was not altered by the stabilization over the past week (+0.25% over 7 days).

The technical setup remains unfavorable: the price moves below its three moving averages, with a 25.11% gap below the MM200 at €117.56. The RSI at 39 indicates persistent selling pressure without tipping into overt overselling, while the MACD remains entrenched in negative territory. The American counterpart Accenture also falls by 3.29% overseas, which acts as a direct sectoral factor on the French value.

Quiet Period Before Half-Yearly Accounts and Rise in Bearish Bets

The calendar places Capgemini in a quiet period this June 30, in anticipation of the first half of 2026 publication. The event will be closely watched after a year marked by a downward revision of sector expectations and a price trajectory that has erased much of the gains from recent years. In terms of valuation, the stock is trading at about 6.8 times the earnings for the current year according to the consensus of surveyed analysts, with an expected growth in earnings per share of 6.7% next year.

Meanwhile, the bearish positioning of funds has intensified: according to consulted declarations, four participants cumulatively hold 2.38% of the capital sold short, up from 0.69% a month ago, a rise of 1.69 points in thirty days. This rapid increase signals that some institutional investors are taking bets against the value or seeking to hedge, though this should not be seen as a massive movement of distrust given the still modest level in absolute terms. The defense of the €87.82 support will be a focal point in the upcoming sessions, as the half-yearly publication approaches.